Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Stroke Division, University Hospitals Neurological institute, Cleveland, OH, USA.
Ann Neurol. 2022 Sep;92(3):364-378. doi: 10.1002/ana.26418. Epub 2022 Jul 25.
This study was undertaken to evaluate functional and safety outcomes for endovascular thrombectomy (EVT) versus medical management (MM) in patients with large vessel occlusion (LVO) and mild neurological deficits, stratified by perfusion imaging mismatch.
The pooled cohort consisted of patients with National Institutes of Health Stroke Scale (NIHSS) < 6 and internal carotid artery (ICA), M1, or M2 occlusions from the Extending the Time for Thrombolysis in Emergecy Neurological Deficits - Intra-Arterial (EXTEND-IA) Trial, Tenecteplase vs Alteplase before Endovascular Thrombectomy in Ischemic Stroke (EXTEND-IA TNK) trials Part I/II and prospective data from 15 EVT centers from October 2010 to April 2020. RAPID software estimated ischemic core and mismatch. Patients receiving primary EVT (EVT ) were compared to those who received primary MM (MM ), including those who deteriorated and received rescue EVT, in overall and propensity score (PS)-matched cohorts. Patients were stratified by target mismatch (mismatch ratio ≥ 1.8 and mismatch volume ≥ 15ml). Primary outcome was functional independence (90-day modified Rankin Scale = 0-2). Secondary outcomes included safety (symptomatic intracerebral hemorrhage [sICH], neurological worsening, and mortality).
Of 540 patients, 286 (53%) received EVT and demonstrated larger critically hypoperfused tissue (Tmax > 6 seconds) volumes (median [IQR]: 64 [26-96] ml vs MM : 40 [14-76] ml, p < 0.001) and higher presentation NIHSS (median [IQR]: 4 [2-5] vs MM : 3 [2-4], p < 0.001). Functional independence was similar (EVT : 77.4% vs MM : 75.6%, adjusted odds ratio [aOR] = 1.29, 95% confidence interval [CI] = 0.82-2.03, p = 0.27). EVT had worse safety regarding sICH (EVT : 16.3% vs MM : 1.3%, p < 0.001) and neurological worsening (EVT : 19.6% vs MM : 6.7%, p < 0.001). In 414 subjects (76.7%) with target mismatch, EVT was associated with improved functional independence (EVT : 77.4% vs MM : 72.7%, aOR = 1.68, 95% CI = 1.01-2.81, p = 0.048), whereas there was a trend toward less favorable outcomes with primary EVT (EVT : 77.4% vs MM : 83.3%, aOR = 0.39, 95% CI = 0.12-1.34, p = 0.13) without target mismatch (p = 0.06). Similar findings were observed in a propensity score-matched subpopulation.
Overall, EVT was not associated with improved clinical outcomes in mild strokes due to LVO, and sICH was increased. However, in patients with target mismatch profile, EVT was associated with increased functional independence. Perfusion imaging may be helpful to select mild stroke patients for EVT. ANN NEUROL 2022;92:364-378.
本研究旨在评估血管内血栓切除术(EVT)与医学治疗(MM)在大血管闭塞(LVO)和轻度神经功能缺损患者中的功能和安全性结局,按灌注成像不匹配情况分层。
汇总队列包括来自扩展溶栓时间在急诊神经功能缺损中的应用-动脉内(EXTEND-IA)试验、Tenecteplase 与阿替普酶在缺血性卒中血管内血栓切除前的比较(EXTEND-IA TNK)试验第一/二部分的 NIHSS<6 和颈内动脉(ICA)、M1 或 M2 闭塞患者,以及 2010 年 10 月至 2020 年 4 月期间 15 个 EVT 中心的前瞻性数据。RAPID 软件估计缺血核心和不匹配。将接受直接 EVT(EVT)的患者与接受直接 MM(MM)的患者进行比较,包括那些恶化并接受了挽救性 EVT 的患者,在总体和倾向评分(PS)匹配队列中进行比较。患者按目标不匹配(不匹配比≥1.8 和不匹配体积≥15ml)进行分层。主要结局是功能独立(90 天改良 Rankin 量表评分=0-2)。次要结局包括安全性(症状性颅内出血[sICH]、神经恶化和死亡率)。
在 540 例患者中,286 例(53%)接受了 EVT,表现出更大的临界低灌注组织(Tmax>6 秒)体积(中位数[IQR]:64[26-96]ml 比 MM:40[14-76]ml,p<0.001)和更高的初始 NIHSS(中位数[IQR]:4[2-5]比 MM:3[2-4],p<0.001)。功能独立情况相似(EVT:77.4%比 MM:75.6%,调整后的优势比[aOR]1.29,95%置信区间[CI]0.82-2.03,p=0.27)。EVT 在 sICH(EVT:16.3%比 MM:1.3%,p<0.001)和神经恶化(EVT:19.6%比 MM:6.7%,p<0.001)方面的安全性更差。在 414 例(76.7%)有目标不匹配的患者中,EVT 与改善的功能独立相关(EVT:77.4%比 MM:72.7%,aOR 1.68,95%CI 1.01-2.81,p=0.048),而在没有目标不匹配的情况下,直接 EVT 的结局趋势较差(EVT:77.4%比 MM:83.3%,aOR 0.39,95%CI 0.12-1.34,p=0.13)。在倾向评分匹配的亚组中也观察到了类似的发现。
总的来说,EVT 与轻度 LVO 卒中患者的临床结局改善无关,sICH 发生率增加。然而,在有目标不匹配特征的患者中,EVT 与功能独立性的提高相关。灌注成像可能有助于选择轻度卒中患者进行 EVT。